Clinical comparison of two beta-receptor stimulants and one parasympatholytic drug in chronic obstructive lung disease.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents; D002986:Clinical Trials as Topic; D006801:Humans; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D008168:Lung / Q000503:physiopathology; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D009921:Metaproterenol / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D010640:Phenothiazines / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D011674:Pulse; D012119:Respiration / Q000187:drug effects; D013147:Spirometry
D000605:Amino Alcohols; D001993:Bronchodilator Agents; D010640:Phenothiazines; D010919:Placebos; D009921:Metaproterenol